Related Experiment Videos
[High Dose Rate 192Ir-Microselectron]
J K Bentzen1, H H Ockelmann, H S Hansen
1Onkologisk afdeling, Rigshospitalet, København.
Ugeskrift for Laeger
|October 1, 1990
Summary
The new HDR 192Ir-Microselectron enables precise high-dose-rate brachytherapy for lung cancer via fiberbronchoscope. Promising results also suggest potential for treating esophageal, prostate, head and neck, breast, and intraabdominal tumors.
Area of Science:
- Oncology
- Medical Physics
- Radiotherapy
Context:
- Introducing the High-Dose-Rate (HDR) 192Ir-Microselectron, a novel remote afterloading apparatus.
- Utilizes a compact, high-activity 192Iridium (192Ir) source (370 GBq / 10 Ci).
- Source dimensions allow treatment via catheters as small as 1.9 mm.
Purpose:
- To describe the capabilities and preliminary clinical applications of the HDR 192Ir-Microselectron.
- To highlight its potential for minimally invasive cancer treatments.
- To evaluate its efficacy in various oncological indications.
Summary:
- The HDR 192Ir-Microselectron facilitates endobronchial radiotherapy for lung cancer patients under local anesthesia using a fiberbronchoscope.
- Preliminary studies show promising outcomes in treating cancers of the esophagus, prostate, head and neck, and breast.
- Demonstrates significant potential for treating non-resectable intraabdominal tumors during surgery.
Impact:
- Enables precise, targeted radiotherapy delivery with a minimally invasive approach.
- Expands treatment options for challenging tumor locations, including lung and intraabdominal cancers.
- Offers a promising new modality for improving patient outcomes in various cancer types.